-
Mashup Score: 1STOP & GO: discontinuing TPO-RA in chronic ITP - 13 day(s) ago
In this issue of Blood, Cottu and colleagues present data from the STOPAGO study demonstrating that nearly half of the patients with chronic ITP who achiev
Source: ashpublications.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 43
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#SABCS24 Part 2: Highlights w/ @jamecancerdoc ✅ #EUROPA ✅ #TAILORx ✅ #PADMA ✅ #EMBER3 Full 📢: ⭐️ https://t.co/26pwXj5j8g ⭐️ https://t.co/jc9mu7uaBn ⭐️Also on “Oncology Brothers” podcast #OncTwitter #bcsm @TargetedOnc #BreastCancer #MedTwitter https://t.co/fu8i4lbiCA
-
-
Mashup Score: 9
Same-day vitamin B12 and pemetrexed administration is a safe practice in NSCLC and malignant pleural mesothelioma patients.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Partners & KOLsTweet-
My own practice has been same day B12 treatment as well (https://t.co/vkp3QURdHk from @RoswellPark) But even within our group, this practice differs significantly where some feel very strongly about delaying chemo if B12 is not given a few days prior.
-
-
Mashup Score: 30
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#GISeries: #Hepatocellular Ca 3/4: Rx for Intermediate HCC w/ @ma5RN @ec2904 🌟Transplant, loco-regional, & Systemic options Full 🗣️ - https://t.co/mtlLWeo0sk - https://t.co/vmIuRD6r5p - Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism @OncoAlert https://t.co/c6EEicJNh3
-
-
Mashup Score: 45SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA - 20 day(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#SABCS24 Part1: Highlights w/ @laura_huppert ✅ #INSEMA ✅ #KN522 ✅ #OlympiA Full 📢: ⭐️ https://t.co/PzSPh9KsBz ⭐️ https://t.co/A2lFpwXbJR ⭐️Also on “Oncology Brothers” podcast ⭐️Part 2 & 3 w/ @jamecancerdocan & @stolaney1 to follow #OncTwitter #bcsm @TargetedOnc https://t.co/LMIQHnMelC
-
-
Mashup Score: 20Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski - 23 day(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#ASH24 #Myeloma Highlights w/ @Myeloma_Doc - #AQUILA - Quad Induction - #CARTITUDE4 - IVIG w/ Bispecific Abs Full 📢: - https://t.co/7oghyRqGwO - https://t.co/MArtOkgqG3 - Also on the “Oncology Brothers” podcast #HemeTwitter #mmsm @TargetedOnc #OncTwitter https://t.co/sjy5ihRcly
-
-
Mashup Score: 4Oncology Brothers Live Event (ASCO GI 25) - 26 day(s) ago
Get tickets online for Oncology Brothers Live Event (ASCO GI 25) here.
Source: oncologybrothers.regfox.comCategories: General Medicine News, Partners & KOLsTweet-
Register here: https://t.co/uP6375KKUS Look forward to seeing/meeting you all in person!! https://t.co/w33YvJXxWi
-
-
Mashup Score: 35
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#GISeries: #Zanidatamab was recently approved based off #HerizonBTC01! We 🗣️ design, findings, sequencing and AEs/management w/ @DrShubhamPant Full Discussion: - https://t.co/yS8tS3MDjL - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism #GI25 https://t.co/wzX2T8TWjA
-
-
Mashup Score: 10
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#ASH24 #CLL Highlights w/ #JohnAllan - #AMPLIFY - #SEQUOIA - #TRANSCEND (CART in CLL) Full 📢: - https://t.co/bclUoJxr6s - https://t.co/4R6O5IL5wK - Also on the “Oncology Brothers” podcast #MedTwitter #HemeTwitter #lymsm @TargetedOnc #OncTwitter https://t.co/VcYeJbHBzq
-
-
Mashup Score: 23CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy - 1 month(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#ToxCheck: CART is approved for multiple heme malignancies. Join @SurbhiSidanaMD & @Lymphoma_Doc as we discuss key AEs & management strategies: Full 📢 ⭐️ https://t.co/un7L9NX4FR ⭐️ https://t.co/O9Dy7oWWhf ⭐️ “Oncology Brothers” podcast #MedTwitter #HemeTwitter #mmsm #lymsm https://t.co/hcZbWMs16N
-
RT @BijoyTelivala: https://t.co/oLuDGs57Kl Small numbers but provides reassurance that we can safely stop TPO agonist in chronic ITP when…